• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐带血来源的人肥大细胞祖细胞和成熟肥大细胞上白细胞免疫球蛋白样受体的差异表达。

Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.

作者信息

Tedla Nicodemus, Lee Chyh-Woei, Borges Luis, Geczy Carolyn L, Arm Jonathan P

机构信息

Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney, Australia.

出版信息

J Leukoc Biol. 2008 Feb;83(2):334-43. doi: 10.1189/jlb.0507314. Epub 2007 Nov 12.

DOI:10.1189/jlb.0507314
PMID:17998301
Abstract

The leukocyte Ig-like receptors (LILRs) comprise a family of cell-surface immunoregulatory receptors with activating and inhibitory members. The inhibitory LILRs possess cytoplasmic ITIMs that down-regulate signaling by nonreceptor tyrosine kinase cascades. The activating members have a truncated cytoplasmic domain and signal through the FcR gamma chain. We examined the expression of LILRs on human mast cells during their development in vitro. Progenitor mast cells expressed cell surface inhibitory LILRB1, -B2, -B3, and -B4 and activating LILRA1. However, although mature cord blood-derived mast cells (hMCs) had detectable mRNA encoding multiple LILRs, none were expressed on the cell surface. Culture of progenitor mast cells or hMCs with various cytokine combinations failed to retain or induce cell surface expression of the LILRs. It is interesting that hMCs expressed LILRB5 in cytoplasmic granules and upon cross-linking of the high-affinity IgE receptor, released LILRB5 into the culture medium. Our results demonstrate that LILRs are developmentally regulated in human mast cells and that LILRB5 is expressed in mast cell granules and the release of soluble LILRB5 following IgE FcR-dependent stimulation, which has potential for amplification of mast cell-dependent, inflammatory responses.

摘要

白细胞免疫球蛋白样受体(LILRs)是一类细胞表面免疫调节受体家族,包括激活型和抑制型成员。抑制型LILRs具有细胞质免疫受体酪氨酸抑制基序(ITIMs),可通过非受体酪氨酸激酶级联反应下调信号传导。激活型成员具有截短的细胞质结构域,并通过FcRγ链进行信号传导。我们研究了人肥大细胞在体外发育过程中LILRs的表达情况。祖肥大细胞表达细胞表面抑制型LILRB1、-B2、-B3和-B4以及激活型LILRA1。然而,尽管成熟的脐血来源肥大细胞(hMCs)有可检测到的编码多种LILRs的mRNA,但细胞表面均未表达。用各种细胞因子组合培养祖肥大细胞或hMCs未能保留或诱导LILRs的细胞表面表达。有趣的是,hMCs在细胞质颗粒中表达LILRB5,并且在高亲和力IgE受体交联后,将LILRB5释放到培养基中。我们的结果表明,LILRs在人肥大细胞中受到发育调控,并且LILRB5在肥大细胞颗粒中表达,以及在IgE FcR依赖性刺激后可溶性LILRB5的释放,这有可能放大肥大细胞依赖性炎症反应。

相似文献

1
Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.脐带血来源的人肥大细胞祖细胞和成熟肥大细胞上白细胞免疫球蛋白样受体的差异表达。
J Leukoc Biol. 2008 Feb;83(2):334-43. doi: 10.1189/jlb.0507314. Epub 2007 Nov 12.
2
Recombinant human (rh)IL-4-mediated apoptosis and recombinant human IL-6-mediated protection of recombinant human stem cell factor-dependent human mast cells derived from cord blood mononuclear cell progenitors.重组人(rh)白细胞介素-4介导的凋亡以及重组人白细胞介素-6介导的对源自脐血单个核细胞祖细胞的重组人干细胞因子依赖型人肥大细胞的保护作用。
J Immunol. 1999 Nov 1;163(9):5105-15.
3
Functional expression of high-affinity receptor for immunoglobulin E on mast cells precedes that of tryptase during differentiation from human bone marrow-derived CD34 progenitors cultured in the presence of stem cell factor and interleukin-6.在存在干细胞因子和白细胞介素-6的情况下,从人骨髓来源的CD34祖细胞分化而来的肥大细胞上,免疫球蛋白E高亲和力受体的功能性表达先于类胰蛋白酶的表达。
Clin Exp Allergy. 2004 Jun;34(6):917-25. doi: 10.1111/j.1365-2222.2004.01971.x.
4
Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells.脐血祖细胞来源的和成人祖细胞来源的人肥大细胞之间的差异基因表达谱
Immunol Lett. 2005 May 15;98(2):265-71. doi: 10.1016/j.imlet.2004.12.001. Epub 2005 Jan 4.
5
Inhibition of pathologic inflammation by leukocyte Ig-like receptor B4 and related inhibitory receptors.白细胞免疫球蛋白样受体B4及相关抑制性受体对病理性炎症的抑制作用
Immunol Rev. 2007 Jun;217:222-30. doi: 10.1111/j.1600-065X.2007.00522.x.
6
Detection of differentiation- and activation-linked cell surface antigens on cultured mast cell progenitors.检测培养的肥大细胞祖细胞上与分化和激活相关的细胞表面抗原。
Allergy. 2005 Oct;60(10):1248-55. doi: 10.1111/j.1398-9995.2005.00865.x.
7
Comparison of short term in vitro cultured human mast cells from different progenitors - Peripheral blood-derived progenitors generate highly mature and functional mast cells.不同祖细胞来源的人肥大细胞短期体外培养比较——外周血来源的祖细胞可产生高度成熟且功能完备的肥大细胞。
J Immunol Methods. 2008 Jul 31;336(2):166-74. doi: 10.1016/j.jim.2008.04.016. Epub 2008 May 16.
8
Expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium: correlations to disease activity.类风湿性滑膜中活化性和抑制性白细胞免疫球蛋白样受体的表达:与疾病活动的相关性
Tissue Antigens. 2011 Apr;77(4):305-16. doi: 10.1111/j.1399-0039.2011.01633.x.
9
Cultured human intestinal mast cells express functional IL-3 receptors and respond to IL-3 by enhancing growth and IgE receptor-dependent mediator release.培养的人肠道肥大细胞表达功能性白细胞介素-3受体,并通过促进生长和依赖免疫球蛋白E受体的介质释放来对白细胞介素-3作出反应。
Eur J Immunol. 2002 Aug;32(8):2308-16. doi: 10.1002/1521-4141(200208)32:8<2308::AID-IMMU2308>3.0.CO;2-X.
10
Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.抑制性受体与MHC I类分子之间的顺式结合可调节肥大细胞的活化。
J Exp Med. 2007 Apr 16;204(4):907-20. doi: 10.1084/jem.20060631. Epub 2007 Apr 9.

引用本文的文献

1
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族(LILRBs):结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
2
Therapeutic targeting of tumour-associated macrophage receptors.肿瘤相关巨噬细胞受体的治疗靶向作用
Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025.
3
Eph Receptors Activate Myeloid Checkpoint Receptor LILRB5 to Support Tumor Development.
Eph受体激活髓系检查点受体LILRB5以支持肿瘤发展。
Cancer Immunol Res. 2025 Jun 4;13(6):821-835. doi: 10.1158/2326-6066.CIR-24-0737.
4
Targeting "don't eat me" signal: breast cancer immunotherapy.靶向“别吃我”信号:乳腺癌免疫疗法
Breast Cancer Res Treat. 2025 Jun;211(2):277-292. doi: 10.1007/s10549-025-07659-w. Epub 2025 Mar 18.
5
Conformational Alterations of the Cell Surface of Monomeric and Dimeric β2m-Free HLA-I (Proto-HLA) May Enable Novel Immune Functions in Health and Disease.单体和二聚体无β2m HLA-I(原HLA)细胞表面的构象改变可能在健康和疾病中赋予新的免疫功能。
Curr Issues Mol Biol. 2024 Jul 4;46(7):6961-6985. doi: 10.3390/cimb46070416.
6
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
7
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.靶向 LILRB1 在癌症固有和适应性免疫检查点治疗中的研究进展。
Front Immunol. 2023 Sep 13;14:1240275. doi: 10.3389/fimmu.2023.1240275. eCollection 2023.
8
Expression analysis of Carassius auratus-leukocyte-immune-type receptors (CaLITRs) during goldfish kidney macrophage development and in activated kidney leukocyte cultures.金鱼肾巨噬细胞发育过程中及活化的肾白细胞培养物中鲫鱼白细胞免疫型受体(CaLITRs)的表达分析
Immunogenetics. 2023 Apr;75(2):171-189. doi: 10.1007/s00251-023-01298-5. Epub 2023 Feb 18.
9
Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets.用于治疗急性髓系白血病的抗体疗法:探索当前和新兴的治疗靶点。
Expert Opin Investig Drugs. 2023 Feb;32(2):107-125. doi: 10.1080/13543784.2023.2179482. Epub 2023 Feb 26.
10
LILRB4, an immune checkpoint on myeloid cells.LILRB4,一种髓系细胞上的免疫检查点。
Blood Sci. 2022 May 17;4(2):49-56. doi: 10.1097/BS9.0000000000000109. eCollection 2022 Apr.